Wnt pathway, an essential role in bone regeneration

Journal of Cellular Biochemistry

Volumn 106, Issue 3, 2009, Pages 353-362

  Chen, Yan ^a   Alman, Benjamin A ^a,b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

Beta catenin; Bone regeneration; Wnt

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ARTICLE; BONE MASS; BONE REGENERATION; ENCHONDRAL OSSIFICATION; FACIAL BONE; FRACTURE HEALING; HUMAN; MESENCHYME CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; ANIMAL; FRACTURE; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; BONE REGENERATION; FRACTURES, BONE; HUMANS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 62649138786     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22020     Document Type: Article

References (101)

1. Akiyama T. 2000. Wnt/heta-catenin signaling. Cytokine Growth Factor Rev 11:273-282.
2. Altman DA, Titus L, Hair GA, Boden SD. 1999. Molecular biology and spinal disorders. A survey for the clinician. Spine 24:723-730.
3. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. 2001. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 3:683-686.
4. Baksh D, Tuan RS. 2007. Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol 212:817-826.
5. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. 1999. Growth factor regulation of fracture repair. J Bone Miner Res 14:1805-1815.
6. Behrens J. 2000. Cross-regulation of the Wnt signalling pathway: A role of MAP kinases. J Cell Sci 113(Pt 6): 911-919.
7. Boland GM, Perkins G, Hall DJ, Tuan RS. 2004. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 93:1210-1230.
8. Borycki A, Brown AM, Emerson CP, Jr. 2000. Shh and Wnt signaling pathways converge to control Gli gene activation in avian somites. Development 127:2075-2087.
9. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor- related protein 5. N Engl J Med 346:1513-1521.
10. Bridgewater LC, Lefebvre V, de Crombrugghe B. 1998. Chondrocyte-specific enhancer elements in the Collla2 gene resemble the Col2al tissue-specific enhancer. J Biol Chem 273:14998-15006.
11. Bruder SP, Fink DJ, Caplan AI. 1994. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283-294.
12. Cadigan KM, Nusse R. 1997. Wnt signaling: A common theme in animal development. Genes Dev 11:3286-3305.
13. Carron C, Bourdelas A, Li HY, Boucaut JC, Shi DL. 2005. Antagonistic interaction between IGF and Wnt/JNK signaling in convergent extension in Xenopus embryo. Mech Dev 122:1234-1247.
14. Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors 22:233-241.
15. Chen AE, Ginty DD, Fan CM. 2005. Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317-322.
16. Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R, Alman BA. 2007a. Beta-catenin signaling plays a disparate role in different phases of fracture repair: Implications for therapy to improve bone healing. PLoS Med 4:e249.
17. Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC, Alman BA. 2007b. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 282:526-533.
18. Clement-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R, Rawadi G. 2005. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102:17406-17411.
19. Day TF, Yang Y. 2008. Wnt and hedgehog signaling pathways in bone development. J Bone Joint Surg Am 90(Suppl l):19-24.
20. Day TF, Quo X, Garrett-Beal L, Yang Y. 2005. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750.
21. De Biase P, Capanna R. 2005. Clinical applications of BMPs. Injury 36(Suppl 3):S43-S46.
22. Dimitriou R, Tsiridis E, Giannoudis PV. 2005. Current concepts of molecular aspects of bone healing, injury 36:1392-1404.
23. Ducy P. 2000. Cbfal: A molecular switch in osteoblast biology. Dev Dyn 219:461-471.
24. Ducy P, Karsenty G. 2000. The family of bone morphogenetic proteins. Kidney Int 57:2207-2214.
25. Dunwoodie SL, Clements M, Sparrow DB, Sa X, Conlon RA, Beddington RS. 2002. Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene D113 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development 129:1795-1806.
26. Eastman Q, Grosschedl R. 1999. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11:233-240.
27. Einhorn TA. 1998. The cell and molecular biology of fracture healing. Clin Orthop Relat Res: S7-S21.
28. Enomoto-lwamoto M, Kitagaki J, Koyarna E, Tamamura Y, Wu C, Kanatani N, Koike T, Okada H, Komori T, Yoneda T, Church V, Francis-West PH, Kurisu K, Nohno T, Pacifici M, Iwamoto M. 2002. The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeleto- genesis. Dev Biol 251:142-156.
29. Ferguson CM, Miclau T, Hu D, Alpern E, Helms JA. 1998. Common molecular pathways in skeletal morphogenesis and repair. Ann NY Acad Sci 857:33-42.
30. Ferguson C, Alpem E, Miclau T, Helms JA. 1999. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57-66.
31. Fischer L, Boland G, Tuan RS. 2002 a. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277:30870-30878.
32. Fischer L, Boland G, Tuan RS. 2002b. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem 84:816-831.
33. French DM, Kaul RJ, D'Souza AL, Crowley CW, Bao M, Frantz GD, Filvaroff EH, Desnoyers L. 2004. WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165:855-867.
34. Gavin BJ, McMahon JA, McMahon AP. 1990. Expression of multiple novel Wnt-1/int-l-related genes during fetal and adult mouse development. Genes Dev 4:2319-2332.
35. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
36. Gordon MD, Nusse R. 2006. Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429-22433.
37. Gregory CA, Gunn WG, Reyes E, Smolarz AJ, Munoz J, Spees JL, Prockop DJ. 2005. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann NY Acad Sci 1049:97-106.
38. Habas R, Dawid IB. 2005. Dishevelled and Wnt signaling: Is the nucleus the final frontier? J Biol 4:2.
39. Habas R, Dawid IB, He X. 2003. Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev 17:295-309.
40. Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT. 2002. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem 277: 30177-30182.
41. Hartikka H, Makitie 0, Mannikko M, Doria AS, Daneman A, Cole WG, Ala- Kokko L, Sochett EB. 2005. Heterozygous mutations in the LDL receptor- related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 20:783-789.
42. Hartmann C, Tabin CJ. 2000. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127:3141-3159.
43. Hartmann C, Tabin CJ. 2001. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104:341-351.
44. Heisenberg CP, Tada M, Rauch GJ, Saude L, Concha ML, Geisler R, Stemple DL, Smith JC, Wilson SW. 2000. Silberblick/Wntl 1 mediates convergent extension movements during zebrafish gastrulation. Nature 405: 76-81.
45. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. 2005. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738.
46. Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, Kronenberg HM, Teitelbaum SL, Ross FP, Kopan R, Long F. 2008. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 14:306-314.
47. Huelsken J, Behrens J. 2002. The Wnt signalling pathway. J Cell Sci 115: 3977-3978.
48. Hussein SM, Duff EK, Sirard C. 2003. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278:48805-48814.
49. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyarna S, Kikuchi A. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17:1371-1384.
50. Johnson ML, Kamel MA. 2007. The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19:376-382.
51. Kahler RA, Westendorf J J. 2003. Lymphoid enhancer factor-1 and beta- catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem 278:11937-11944.
52. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, Wigner NA, Toben D, Jacobsen KA, Al-Sebaei MO, Song M, Trackman PC, Morgan EF, Gerstenfeld LC, Barnes GL. 2007. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22:1903-1912.
53. Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG. 2007. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 89:347-357.
54. Karsenty G, Wagner EF. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
55. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. 2002. Cbfal- independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314.
56. Katoh M. 2002. WNT and FGF gene clusters (review). Int J Oncol 21:1269- 1273.
57. Katoh M. 2006. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 17:681- 685.
58. Katoh M. 2007. WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13:4042-4045.
59. Kawakami Y, Wada N, Nishimatsu SI, Ishikawa T, Noji S, Nohno T. 1999. Involvement of Wnt-5a in chondrogenic pattern formation in the chick limb bud. Dev Growth Differ 41:29-40.
60. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Pena J, Johnson RL, Belmonte JC, Tabin CJ. 1998. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 280: 1274-1277.
61. Kim JB, Leucht P, Lam K, Luppen C, Ten Berge D, Nusse R, Helms JA. 2007. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res 22:1913- 1923.
62. Kitagaki J, Iwamoto M, Liu JG, Tamamura Y, Pacifci M, Enomoto-Iwamoto M. 2003. Activation of beta-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification. Osteoarthritis Cartilage 11:36-43.
63. Koay MA, Brown MA. 2005. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol Med 11:129-137.
64. Kohn AD, Moon RT. 2005. Wnt and calcium signaling: Beta-catenin-inde- pendent pathways. Cell Calcium 38:439-446.
65. Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Halladay DL, Frolik CA, Engler T, Wei T, Kriauciunas A, Martin TJ, Sato M, Bryant HU, Ma YL. 2006. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21:910-920.
66. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. 1997. S0X9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha 1(II) collagen gene. Mol Cell Biol 17:2336-2346.
67. Leucht P, Kim JB, Helms JA. 2008. Beta-catenin-dependent Wnt signaling in mandibular bone regeneration. J Bone Joint Surg Am 90(Suppl 1): 3-8.
68. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high- bone-mass trait. Am J Hum Genet 70:11-19.
69. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP. 2004. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131:1309-1318.
70. McKibbin B. 1978. The biology of fracture healing in long bones. J Bone Joint Surg Br 60-B:150-162.
71. Meng X, Poon R, Zhang X, Cheah A, Ding Q, Hui CC, Alman B. 2001. Suppressor of fused negatively regulates beta-catenin signaling. J Biol Chem 276:40113-40119.
72. Moon RT, Bowerman B, Boutros M, Perrimon N. 2002. The promise and perils of Wnt signaling through beta-catenin. Science 296:1644-1646.
73. Nelson WJ, Nusse R. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487.
74. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403:781-785.
75. Noble W, Planel E, Zehr C, 01m V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K. 2005. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102:6990-6995.
76. Noden DM, Trainor PA. 2005. Relations and interactions between cranial mesoderm and neural crest populations. J Anat 207:575-601.
77. Ogden SK, Ascano M, Jr., Stegman MA, Robbins DJ. 2004. Regulation of Hedgehog signaling: A complex story. Biochem Pharmacol 67:805-814.
78. Olsen BR, Reginato AM, Wang W. 2000. Bone development. Annu Rev Cell Dev Biol 16:191-220.
79. Phiel CJ, Klein PS. 2001. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 41:789-813.
80. Reddi AH. 1998. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247-252.
81. Ross DA, Kadesch T. 2001. The notch intracellular domain can function as a coactivator for LEF-1. Mol Cell Biol 21:7537-7544.
82. Schou M. 2001. Lithium treatment at 52. J Affect Disord 67:21-32.
83. Sciaudone M, Gazzerro E, Priest L, Delany AM, Canalis E. 2003. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144:5631-5639.
84. Seto ES, Bellen HJ. 2004. The ins and outs of Wingless signaling. Trends Cell Biol 14:45-53.
85. Sheldahl LC, Park M, Malbon CC, Moon RT. 1999. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein- dependent manner. Curr Biol 9:695-698.
86. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in Presenilin-l-deficient mice. Cell 89:629-639.
87. St-Jacques B, Hammerschmidt M, McMahon AP. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13:2072-2086.
88. Thompson Z, Miclau T, Hu D, Helms JA. 2002. A model for intramembranous ossification during fracture healing. J Orthop Res 20:1091-1098.
89. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD, Jr. 2003. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349:2483-2494.
90. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta- catenin degradation. J Cell Biol 162:899-908.
91. Torres MA, Yang-Snyder J A, Purcell SM, DeMarais AA, McGrew LL, Moon RT. 1996. Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development. J Cell Biol 133:1123-1 137.
92. Van Den Berg DJ, Sharma AK, Bruno E, Hoffman R. 1998. Role of members of the Wnt gene family in human hematopoiesis. Blood 92:3189-3202.
93. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT. 2003. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrula- tion movements. Curr Biol 13:680-685.
94. Vestergaard P, Rejnmark L, Mosekilde L. 2005. Reduced relative risk of fractures among users of lithium. Calcif Tissue Int 77:1-8.
95. 2+, and cyclic GMP: Visualizing Frizzled functions. Science 300:1529-1530.
96. Westendorf JJ, Kahler RA, Schroeder TM. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39.
97. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL, Van der Ploeg LH, Sisodia SS. 1997. Presenilin 1 is required for Notchl and Dill expression in the paraxial mesoderm. Nature 387:288-292.
98. Wu W, Glinka A, Delius H, Niehrs C. 2000. Mutual antagonism between dickkopfl and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol 10:1611-1614.
99. Yang Y. 2003. Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis. Birth Defects Res C Embryo Today 69:305-317.
100. Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS. 2003. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 278:33067-33077.
101. Zhong N, Gersch RP, Hadjiargyrou M. 2006. Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone 39:5-16.